As the USA deals with the challenges of bioterrorism, the country's drugindustry, through the Pharmaceutical Research and Manufacturers of America, has created a taskforce on emergency preparedness, to assist the federal government in any way it can.
Chaired by Aventis Pharma's chief executive, Richard Markham, the taskforce has already met with Health and Human Services Secretary Tommy Thompson and members of Congress, and has said it will be available to meet on an ongoing basis with key congressional leaders and committees on both sides of the aisle in both the House and the Senate.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze